Section 5 Maternal Health Outcomes
5.1 Gestational diabetes by year, Nova Scotia, 2010-2019
Figure 5.1: Gestational diabetes by year, Nova Scotia, 2010-2019
ᵃ Among women without pre-existing diabetes.
Note: Diabetes mellitus first detected in pregnancy as recorded in the medical record. Please note that the criteria for the diagnosis of gestational diabetes were revised by Diabetes Canada (formerly the Canadian Diabetes Association) in 2013. Therefore, the rates of gestational diabetes were expected to increase as the new criteria are adopted across Nova Scotia, starting approximately in late 2014.
5.2 Gestational hypertension by year, Nova Scotia, 2010-2019
Figure 5.2: Gestational hypertension by year, Nova Scotia, 2010-2019
ᵃ Among women without pre-existing hypertension.
Note: Gestational hypertension is hypertension that is first detected after the 20th week of gestation. Gestational hypertension with significant proteinuria includes those cases denoted as such; severe pre-eclampsia; HELLP syndrome (Hemolysis, Elevated Liver Enzymes, Low Platelets); and eclampsia.
5.3 Pre-eclampsia by year, Nova Scotia, 2010-2019
Figure 5.3: Pre-eclampsia by year, Nova Scotia, 2010-2019
## Duplicate column names found in molten data.table. Setting unique names using 'make.names'Note: Pre-eclampsia includes women coded as having gestational hypertension with significant proteinuria, moderate or severe pre-eclampsia, HELLP syndrome (Hemolysis, Elevated Liver Enzymes, Low Platelets), eclampsia, or pre-existing hypertension with superimposed proteinuria.
5.4 Placenta previa by year, Nova Scotia, 2010-2019
Figure 5.4: Placenta previa by year, Nova Scotia, 2010-2019
Note: Placenta previa is diagnosed when the placenta entirely or partially covers the opening of the uterus (cervix). The diagnosis is not made on ultrasound alone and must be confirmed clinically.
5.5 Placental abruption by year, Nova Scotia, 2010-2019
Figure 5.5: Placental abruption by year, Nova Scotia, 2010-2019
Note: Placental abruption is defined as bleeding from the placental site due to the partial or complete separation of the placenta. The diagnosis is not made on ultrasound alone and must be confirmed clinically.
5.6 Perineal laceration deliveries by parity and year, Nova Scotia, 2010-2019
Figure 5.6: Perineal laceration deliveries by parity and year, Nova Scotia, 2010-2019
ᵃ With known partner status.
Note: Maternal perineal laceration, rupture or tear during delivery involving the pelvic floor, perineal muscles, or vaginal muscles (2ⁿᵈ degree), anal sphincter (3ʳᵈ degree), or rectal mucosa (4ᵗʰ degree).
5.7 Postpartum hemorrhage by year, Nova Scotia, 2010-2019
Figure 5.7: Postpartum hemorrhage by year, Nova Scotia, 2010-2019
Note: Postpartum hemorrhage is diagnosed if, after the delivery of the fetus, excessive maternal bleeding occurs from the genital tract with an estimated blood loss of greater than 500 mL for vaginal deliveries or 1000 mL for Caesarean section deliveries.
5.8 Maternal blood transfusion by year, Nova Scotia, 2010-2019
Figure 5.8: Maternal blood transfusion by year, Nova Scotia, 2010-2019
Note: One or more maternal transfusions of red blood cells in the antepartum, intrapartum, or postpartum periods.